Passage Bio ^Investors

Passage Bio is a private equity firm located in Philadelphia, Pennsylvania, established in 2018 The firm specializes in investments within the biotechnology sector, focusing on gene therapies and related technologies With a significant investment scale of $216 million, Passage Bio aims to advance innovative therapeutic solutions The firm is committed to supporting companies that are pioneering breakthroughs in genetic medicine Its strategic approach emphasizes collaboration with industry leaders to drive growth and development in the biopharmaceutical landscape